SCHEMBL17258751

SCHEMBL17258751

CCS(=O)(=O)Nc1ccccc1CNC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.46
KDM4A O75164 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA7 P43166 1/20 0.44
CA14 Q9ULX7 1/20 0.44
PSIP1 O75475 1/20 0.43
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
NQO2 P16083 1/20 0.41
MALT1 Q9UDY8 1/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
NAMPT P43490 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
SYK P43405 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21048807 0.91 KCNA5 (0.43) KCNA5KDM4ACA12CA1CA7
SCHEMBL12279905 0.88 ALDH1A1 (0.51) KCNA5KDM4ACA12CA1CA7
SCHEMBL21048924 0.84 HSD17B10 (0.42) KCNA5KDM4ACA12CA1CA7
SCHEMBL28131286 0.82 KCNA5 (0.50) KCNA5KDM4ACA12CA1CA7
SCHEMBL8235396 0.82 KCNA5 (0.50) KCNA5KDM4ACA12CA1CA7
SCHEMBL8018113 0.81 KCNA5 (0.56) KCNA5KDM4ACA12CA1CA7
SCHEMBL30159605 0.81 KCNA5 (0.56) KCNA5KDM4ACA12CA1CA7
SCHEMBL4529177 0.78 KCNA5 (0.47) KCNA5KDM4ACA12CA1CA7
SCHEMBL29075936 0.78 KCNA5 (0.47) KCNA5KDM4ALMNAPOLBNQO2
SCHEMBL4471943 0.78 KDM4A (0.51) KCNA5KDM4ACA12CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3143021-B1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER (US) 2019-06-12 EP disclosed
US-10022376-B2 Pyrazolopyridines and pyrazolopyrimidines PFIZER INC. (US) 2018-07-17 US disclosed
EP-3143021-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES Pfizer Inc (US) 2017-03-22 EP disclosed
US-20170071946-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. (US) 2017-03-16 US disclosed
US-9518052-B2 Pyrazolopyridines and pyrazolopyrimidines PFIZER INC. (US) 2016-12-13 US disclosed
US-20150329542-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. 2015-11-19 US disclosed
WO-2015173683-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. (US) 2015-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10022376-B2 Pyrazolopyridines and pyrazolopyrimidines CBR3, HRH4, REN KCNA5 40/4885KDM4A 3130/4885CA12 2744/4885
US-20150329542-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES HRH2, HRH4, HRH1 KCNA5 66/4885KDM4A 4254/4885CA12 3210/4885
US-20170071946-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES HRH2, HRH4, HRH1 KCNA5 66/4885KDM4A 4254/4885CA12 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.